Medical Device Firm to Launch Trials for Treatment Targeting $12 Billion Incontinence Market

Source: Streetwise Reports   02/14/2018 Anthony Vendetti, an analyst with Maxim Group, shared the results of both a pilot study for stress urinary incontinence and of a recent equity raise by this company. In a Feb. 12, research note, Maxim Group analyst Anthony Vendetti reported that Viveve Medical Inc. (VIVE:NASDAQ) announced, on Jan. 31, 2018, the […]